Alcohol biomarkers

Clinics in Laboratory Medicine

Volumn 32, Issue 3, 2012, Pages 391-406

  Ingall, Glynnis B ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Acetaldehyde adducts; Carbohydrate deficient transferrin; Ethyl glucuronide; Ethyl sulfate; Fatty acid ethyl esters; Phosphatidylethanol

Indexed keywords

ACETALDEHYDE; ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; ETHYL GLUCURONIDE; ETHYL SULFATE; FATTY ACID ESTER; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; PHOSPHATIDYLETHANOL; PHOSPHOLIPID; SULFATE; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ALCOHOL BLOOD LEVEL; ALCOHOL INTOXICATION; ALCOHOL METABOLISM; ALCOHOL TOLERANCE; ALCOHOL USE DISORDER; ALCOHOLISM; CHEMICAL TERATOGENESIS; DIAGNOSTIC VALUE; HAIR LEVEL; HUMAN; INTERMETHOD COMPARISON; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; REVIEW; URINE LEVEL;

ALCOHOL DRINKING; ALCOHOLISM; BIOLOGICAL MARKERS; ETHANOL; HUMANS;

EID: 84865582600     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2012.06.003     Document Type: Review

References (77)

1. The role of biomarkers in the treatment of alcohol use disorders. Substance Abuse treatment Advisory 2006, 5(4). Center for Substance Abuse Treatment, Accessed April 29, 2012. http://www.kap.samhsa.gov/products/manuals/advisory/pdfs/0609_biomarkers.pdf.
2. Hannuksela M., Liisanatti M., Nissinen A., et al. Biochemical markers of alcoholism. Clin Chem Lab Med 2007, 45(8):953-961.
3. Litten R., Bradley A., Moss H. Alcohol biomarkers in applied settings: recent advances and future research opportunities. Alcohol Clin Exp Res 2010, 34(6):955-967.
4. Bakhireva L.N., Savage D.D. Focus on: biomarkers of fetal alcohol exposure and fetal alcohol effects. Alcohol Res Health 2011, 34(1):56-63.
5. Results from the 2010 National Survey on Drug Use and Health: summary of national findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658 2011, Substance Abuse and Mental Health Services Administration, Substance Abuse and Mental Health Services Administration, Rockville (MD), Accessed April 29, 2012. http://www.samhsa.gov/data/NSDUH/2k10Results/Web/HTML/2k10Results.htm.
6. Data and statistics in the United States Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Division of Birth Defects and Developmental Disabilities, In: Fetal alcohol spectrum disorders, Accessed April 29, 2012. http://www.cdc.gov/ncbddd/fasd/data.html.
7. Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion Alcohol Use and Health, In: Alcohol and Public Health Fact Sheets, Accessed April 29, 2012. http://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm.
8. Schuckit M.A. Ethanol and methanol. Goodman & Gilman's The Pharmacological basis of therapeutics 2011, McGraw-Hill, New York, Accessed March 30, 2012. http://www.accesmedicine.com/content.aplx?aID=16666094, 12th edition. L.L. Brunton, B.A. Chabner, B.C. Knollmann (Eds.).
9. Tuma J., Casey C. Dangerous byproducts of alcohol breakdown: focus on adducts. Alcohol Res Health 2003, 27(4):285-290.
10. Niemela O., Alatalo P. Biomarkers of alcohol consumption and related liver disease. Scand J Clin Lab Invest 2010, 70:305-312.
11. Niemela O. Biomarkers in alcoholism. Clin Chim Acta 2007, 377:39-49.
12. Das S., Dhanya L., Vasudevan D. Biomarkers of alcoholism: an updated review. Scand J Clin Lab Invest 2008, 68:81-92.
13. Delanghe J., De Buyzere M. Carbohydrate deficient transferrin and forensic medicine. Clin Chim Acta 2009, 406:1-7.
14. Allen J., Litten R., Fertig J., et al. Carbohydrate-deficient transferrin: an aid to early recognition of alcohol relapse. Am J Addict 2001, 10(Suppl):24-28.
15. Helander A., Wielders J., Jeppsson J., et al. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: II. Performance of a laboratory network running the HPLC candidate reference measurement procedure and evaluation of a candidate reference material. Clin Chem Lab Med 2010, 48(11):1585-1592.
16. Sillanaukee P., Strid N., Allen J., et al. Possible reasons why heavy drinking increases carbohydrate-deficient transferrin. Alcohol Clin Exp Res 2001, 25:34-40.
17. Golka K., Wiese A. Carbohydrate-deficient transferrin (CDT)-a biomarker for long-term alcohol consumption. J Toxicol Environ Health B 2004, 7:319-337.
18. Flemming M., Anton R., Spies C. A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res 2004, 28:1347-1355.
19. Bergstrom J., Helander A. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin Chem Acta 2008, 388:59-67.
20. Koivisto H., Hietala J., Anttila P., et al. Long-term ethanol consumption and macrocytosis: diagnostic and pathogenic implications. J Lab Clin Med 2006, 147(4):191-196.
21. Anton F. Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here?. Alcohol 2001, 25:184-188.
22. Hock B., Schwarz M., Domke I., et al. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (GGT) and mean corpuscular volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction 2005, 100:1477-1486.
23. Hietala J., Koivisto H., Anttila P., et al. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 2006, 41:528-533.
24. Setshedi M., Wands R., de la Monte S. Acetaldehyde adducts in alcoholic liver disease. Oxidat Med Cell Longev 2010, 3(3):178-185.
25. Freeman T., Tuma D., Thiele G., et al. Recent advances in alcohol-induced adduct formation. Alcohol Clin Exp Res 2005, 29(7):1310-1316.
26. Hietala J., Kovisto H., Latvala J., et al. IgAs against acetetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers. Alcohol Clin Exp Res 2006, 30(10):1693-1698.
27. Hazelett S., Liebelt R., Brown W., et al. Evaluation of acetaldehyde-modified hemoglobin and other markers of chronic heavy alcohol use: effects of gender and hemoglobin concentration. Alcohol Clin Exp Res 1998, 22(4):1813-1819.
28. Hurme L., Seppa K., Rajaniem H., et al. Chromatographically identified alcohol-induced haemoglobin adducts as markers of alcohol abuse among women. Eur J Clin Invest 1998, 28:87-94.
29. Toennes A., Wagner M., Kauert G. Application of LC-TOF MS to analysis of hemoglobin acetaldehyde adducts in alcohol detoxification patients. Anal Bioanal Chem 2010, 398:769-777.
30. Dahl H., Stephanson N., Beck O., et al. Comparison of urinary excretion characteristics of ethanol and ethyl glucuronide. J Anal Toxicol 2002, 26:201-204.
31. Wurst F., Dressen S., Allen J., et al. Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption. Addiction 2006, 101:204-211.
32. Helander A., Bottcher M., Fehr C., et al. Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Alcohol Alcohol 2009, 44:55-61.
33. Jatlow P., O'Malley S. Clinical (nonforensic) application of ethyl glucuronide measurement: Are we ready?. Alcohol Clin Exp Res 2010, 34(6):968-975.
34. Stephenson N., Dahl H., Helander A., et al. Direct quantification of ethyl glucuronide in clinical urine samples by liquid chromatograph-mass spectrometry. Ther Drug Monit 2002, 24(5):645-651.
35. Wojcik M., Hawthorne J. Sensitivity of commercial ethyl glucuronide (ETG) testing in screening for alcohol abstinence. Alcohol Alcohol 2007, 42(4):317-320.
36. Reisfield G., Goldberger B., Pesce A., et al. Ethyl glucuronide, ethyl sulfate, and ethanol in urine after intensive exposure to high ethanol content mouthwash. J Anal Toxicol 2011, 35:264-268.
37. Reisfield G., Goldberger B., Crews B., et al. Ethyl glucuronide, ethyl sulfate, and ethanol in urine after sustained exposure to ethanol-based hand sanitizer. J Anal Toxicol 2011, 335:85-91.
38. Helander A., Olsson I., Dahl H. Postcollection synthesis of ethyl glucuronide by bacteria in urine may cause false identification of alcohol consumption. Clin Chem 2007, 53(10):1855-1857.
39. Skipper G., Weinmann W., Thierauf A., et al. Ethyl glulcuronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders. Alcohol Alcohol 2004, 39(5):445-449.
40. Dahl H., Carlsson A., Hillgren K., et al. Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence. Alcohol Alcohol 2011, 46(3):278-282.
41. Helander A., Dahl H. Urinary tract infection: a risk factor for false-negative urinary ethyl glucuronide but not ethyl sulfate in the detection of recent alcohol consumption. Clin Chem 2005, 51:1728-1730.
42. Bottcher M., Beck O., Helander A. Evaluation of a new immunoassay for urinary ethyl glucuronide testing. Alcohol Alcohol 2008, 43(1):46-48.
43. Beyer J., Vo T., Gerostamoulos D., et al. Validated method for the determination of ethylglucuronide and ethylsulfate in human urine. Anal Bioanal Chem 2011, 400:189-196.
44. Favretto D., Nalesso A., Frison G., et al. A novel and effective analytical approach for the LC-MS determination of ethyl glucuronide and ethyl sulfate in urine. Int J Legal Med 2010, 124:161-164.
45. Jung B., Caslavska J., Thormann W. Determination of ethyl sulfate in human serum and urine by capillary zone electrophoresis. J Chromatogr A 2008, 1206:26-32.
46. Hansson P., Caron M., Johnson G., et al. Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal. Alcohol Clin Exp Res 1997, 21(1):108-110.
47. Varga A., Hansson P., Johnson G., et al. Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin Chim Acta 2000, 299:141-150.
48. Nissinen A., Makela S., Vuoristo J., et al. Immunological detection of in vitro formed phosphatidylethanol-an alcohol biomarker-with monoclonal antibodies. Alcohol Clin Exp Res 2008, 32(6):921-927.
49. Wurst M., Thon N., Aradottir S., et al. Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports. Addict Biol 2010, 15:88-95.
50. Hartmann S., Aradottir S., Graf M., et al. Phosphatidylethanol as a sensitive and specific biomarker-comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin. Addict Biol 2006, 12:81-84.
51. Stewart S., Law T., Randall P., et al. Phosphatidylethanol and alcohol consumption in reproductive age women. Alcohol Clin Exp Res 2010, 34(3):488-492.
52. Stewart S., Reuben A., Brzezinski W., et al. Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol 2009, 44(5):464-467.
53. Kip M., Spies C., Neumann T., et al. The usefulness of direct ethanol metabolites in assessing alcohol intake in nonintoxicated male patients in an emergency room setting. Alcohol Clin Exp Res 2008, 32(7):1284-1291.
54. Aradottir S., Gulber A., Gjerss S., et al. Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol 2006, 41(4):431-437.
55. Nalesso A., Viel G., Cecchetto G., et al. Quantitative profiling of phosphatidylethanol molecular species in human blood by liquid chromatography high resolution mass spectrometry. J. Chromatogr. A 2011, 1218:8423-8431.
56. Zheng Y., Beck O., Helander A. Method development for routine liquid chromatography-mass spectrometry measurement of the alcohol biomarker phosphatidylethanol (PEth) in blood. Clin Chim Acta 2011, 412:1428-1435.
57. Borucki K., Dierkes J., Wartberg J., et al. In heavy drinkers, fatty acid ethyl esters remain elevated for up to 99 hours. Alcohol Clin Exp Res 2007, 31(3):423-427.
58. Auwarter V., Sporkert F., Hartwig S., et al. Fatty acid ethyl esters in hair as markers of alcohol consumption: segmental hair analysis of alcoholics, social drinkers, and teetotalers. Clin Chem 2001, 47(12):2114-2123.
59. Chan D., Caprara D., Blanchette P., et al. Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. Clin Biochem 2004, 37:429-438.
60. Kulaga V., Pragst F., Fulga N., et al. Hair analysis of fatty acid ethyl esters in the detection of excessive drinking in the context of fetal alcohol spectrum disorders. Ther Drug Monit 2009, 31(2):262-265.
61. Hastedt M., Herre S., Pragst F., et al. Workplace alcohol testing program by combined use of ethyl glucuronide and fatty acid ethyl esters in hair. Alcohol Alcohol 2012, 47(2):127-132.
62. Pragst F., Rothe M., Moench B., et al. Combined use of fatty acid ethyl esters and ethyl glucuronide in hair for diagnosis of alcohol abuse: interpretation and advantages. Forensic Sci Int 2010, 196:101-110.
63. Pragst F., Yegles M. Determination of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in hair: a promising way for retrospective detection of alcohol abuse during pregnancy?. Ther Drug Monit 2008, 30:255-263.
64. Susse S., Selavka C., Mieczkowski T., et al. Fatty acid ethyl ester concentrations in hair and self-reported alcohol consumption in 644 cases from different origin. Forensic Sci Int 2010, 196:111-117.
65. Wurst F., Alexson S., Wolfersdorf M., et al. Concentration of fatty acid ethyl esters in hair of alcoholics: comparison to other biological state markers and self reported-ethanol intake. Alcohol Alcohol 2004, 39(1):33-38.
66. Yegles M., Labarthe A., Auwarter V., et al. Comparison of ethyl glucuronide and fatty acid ethyl ester concentrations in hair of alcoholics, social drinkers and teetotalers. Forensic Sci Int 2004, 145:167-173.
67. Pichini S., Pellegrini M., Gareri J., et al. Liquid chromatography-tandem mass spectrometry for fatty acid ethyl esters in meconium: assessment of prenatal exposure to alcohol in two European cohorts. J Pharmaceut Biomed Anal 2008, 48:927-933.
68. Bakdash A., Burger P., Goecke T., et al. Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study. Anal Bioanal Chem 2010, 396:2469-2477.
69. Moore C., Jones J., Lewis D. Prevalence of fatty acid ethyl esters in meconium specimens. Clin Chem 2003, 49(1):133-136.
70. Bearer C., Santiago L., O'Riordan M., et al. Fatty acid ethyl esters: quantitative biomarkers for maternal alcohol consumption. J Pediatr 2005, 146:824-830.
71. Goh Y., Hutson J., Lum L., et al. Rates of fetal alcohol exposure among newborns in a high-risk obstetric unit. Alcohol 2010, 44:629-634.
72. Peterson J., Kirchner H., Xue W., et al. Fatty acid ethyl esters in meconium are associated with poorer neurodevelopmental outcomes to two years of age. J Pediatr 2008, 152:788-792.
73. Hutson J., Rao C., Fulga N., et al. An improved method for rapidly quantifying fatty acid ethyl esters in meconium suitable for prenatal alcohol screening. Alcohol 2010, 45:193-199.
74. Consensus of the Society of Hair Testing on hair testing for chronic excessive alcohol consumption Society of Hair Testing, Accessed April 30, 2012. http://www.soht.org/pdf/Revised%20Alcohol%20marker%20Consensus.pdf.
75. Jones J., Jones M., Plate C., et al. Liquid chromatography-tandem mass spectrometry assay to detect ethyl glucuronide in human fingernail: comparison to hair and gender differences. Am J Anal Chem 2012, 3:83-91.
76. Hartwig S., Auwarter V., Pragst F. Effect of hair care and hair cosmetics as markers of chronically elevated alcohol consumption. Forensic Sci Int 2003, 131:90-97.
77. EtOH, a new alcohol biomarker that tests at risk newborns for heavy exposure to alcohol in utero U.S. Drug Testing Laboratories (USDTL), In: Testing services, Accessed April 14, 2012. http://www.usdtl.com/cordstatsetohm.html.